Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)

Author:

Barben Jürg,Castellani Carlo,Munck Anne,Davies Jane C.ORCID,de Winter–de Groot Karin M.,Gartner Silvia,Kashirskaya NataliyaORCID,Linnane Barry,Mayell Sarah J,McColley Susanna,Ooi Chee Y.,Proesmans Marijke,Ren Clement L.,Salinas Danieli,Sands DorotaORCID,Sermet-Gaudelus Isabelle,Sommerburg Olaf,Southern Kevin W

Funder

Imperial Biomedical Research Centre

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Reference46 articles.

1. Newborn screening for cystic fibrosis;Castellani;Lancet Respir Med,2016

2. Inconclusive diagnosis after newborn screening for cystic fibrosis;Munck;Int J Neonatal Screen,2020

3. Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): a new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening;Munck;J Cyst Fibros,2015

4. Cystic fibrosis foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond;Borowitz;J Pediatr,2009

5. New challenges in the diagnosis and management of cystic fibrosis;Levy;J Pediatr,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3